ArticleWorld journal of urology2024

Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study.

Ronja Hietikko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.